Dispositions (Details Textual) ₩ in Millions, $ in Millions	1 Months Ended	3 Months Ended	6 Months Ended
	Apr. 30, 2022 USD ($)	Jun. 30, 2023 USD ($)	Jun. 30, 2023 USD ($)	Mar. 31, 2023 KRW (₩)	Dec. 31, 2022 USD ($)	Mar. 31, 2022
Samsung Bioepis
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Equity, ownership interest		49.90%	49.90%			49.90%
Equity Method Investment, Amount Sold	$ 2,300.0
Samsung Bioepis | Fair Value, Recurring
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Other current assets, receivable		$ 415.2	$ 415.2		$ 798.8
Samsung Bioepis | Payment Due At First Anniversary | Discount rates | Fair Value, Recurring
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Risk-adjusted discount rates		0.066	0.066
Samsung Bioepis
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds from divestiture of interest in joint venture	1,000.0
Payables to divestiture of interest in joint venture	1,300.0
Investment in Samsung Bioepis | ₩				₩ 581.6
Gain on sale of equity interest in Samsung Bioepis		$ 1,500.0	$ 1,500.0
Cumulative translation loss			58.9
Gain on derivative used in net investment hedge			57.0
Additional milestone payment	50.0
Samsung Bioepis | Payment Due At First Anniversary
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Payables to divestiture of interest in joint venture	812.5
Gain (loss) on sale		2.6	13.7
Samsung Bioepis | Payment Due At Second Anniversary
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Payables to divestiture of interest in joint venture	$ 437.5
Gain (loss) on sale		$ 3.6	$ 9.8